The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 12, 2010, Pages 1475-1479

  Shime, N ^a   Kosaka, T ^a   Fujita, N ^a  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HABEKACIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; APACHE; AREA UNDER THE CURVE; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CLEARANCE; EARLY INTERVENTION; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BACTEREMIA; BLOOD; CULTURE MEDIA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 78651269361     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-1024-x     Document Type: Article

References (27)

1. D Pittet D Tarara RP Wenzel 1994 Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality JAMA 271 1598 1601 1:STN:280:DyaK2c3jvVOlsw%3D%3D 10.1001/jama.271.20. 1598 8182812 (Pubitemid 24155620)
2. MJ Richards JR Edwards DH Culver RP Gaynes 2000 Nosocomial infections in combined medical-surgical intensive care units in the United States Infect Control Hosp Epidemiol 21 510 515 1:STN:280:DC%2BD3M%2Fmt1Kjtw%3D%3D 10.1086/501795 10968716
3. SK Fridkin 2001 Increasing prevalence of antimicrobial resistance in intensive care units Crit Care Med 29 N64 N68 1:STN:280:DC%2BD3M3ovVemug%3D%3D 10.1097/00003246-200104001-00002 11292878
4. JM Boyce B Cookson K Christiansen S Hori J Vuopio-Varkila S Kocagöz AY Oztop CM Vandenbroucke-Grauls S Harbarth D Pittet 2005 Meticillin-resistant Staphylococcus aureus Lancet Infect Dis 5 653 663 10.1016/S1473-3099(05)70243-7 16183520 (Pubitemid 41383911)
5. SE Cosgrove G Sakoulas EN Perencevich MJ Schwaber AW Karchmer Y Carmeli 2003 Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis Clin Infect Dis 36 53 59 10.1086/345476 12491202 (Pubitemid 36099097)
6. SE Cosgrove Y Qi KS Kaye S Harbarth AW Karchmer Y Carmeli 2005 The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges Infect Control Hosp Epidemiol 26 166 174 10.1086/502522 15756888 (Pubitemid 40445022)
7. S Shurland M Zhan DD Bradham MC Roghmann 2007 Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus Infect Control Hosp Epidemiol 28 273 279 10.1086/512627 17326017 (Pubitemid 46480725)
8. SD Reed JY Friedman JJ Engemann RI Griffiths KJ Anstrom KS Kaye ME Stryjewski LA Szczech LB Reller GR Corey KA Schulman VG Fowler Jr 2005 Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia Infect Control Hosp Epidemiol 26 175 183 10.1086/502523 15756889 (Pubitemid 40445023)
9. CG Gemmell DI Edwards AP Fraise FK Gould GL Ridgway RE Warren Joint Working Party of the British Society for Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association 2006 Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK J Antimicrob Chemother 57 589 608 1:CAS:528:DC%2BD28Xis1GltLg%3D 10.1093/jac/dkl017 16507559
10. EH Ibrahim G Sherman S Ward VJ Fraser MH Kollef 2000 The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Chest 118 146 155 1:STN:280:DC%2BD3czpsVKltA%3D%3D 10.1378/chest.118.1.146 10893372
11. L Leibovici M Drucker H Konigsberger Z Samra S Harrari S Ashkenazi SD Pitlik 1997 Septic shock in bacteremic patients: risk factors, features and prognosis Scand J Infect Dis 29 71 75 1:STN:280:DyaK2s3ms1GntA%3D%3D 10.3109/00365549709008668 9112302
12. AO Guilarde MD Turchi CM Martelli MG Primo 2006 Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital J Hosp Infect 63 330 336 1:STN:280:DC%2BD28zlt1Cmtw%3D%3D 10.1016/j.jhin.2006.02.011 16713018 (Pubitemid 43812197)
13. T Iwamoto Y Kagawa M Kojima 2003 Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin Biol Pharm Bull 26 876 879 1:CAS:528:DC%2BD3sXls1KnsLY%3D 10.1248/bpb.26.876 12808304
14. SL Kane RJ Weber JF Dasta 2003 The impact of critical care pharmacists on enhancing patient outcomes Intensive Care Med 29 691 698 12665997
15. I Harding AP MacGowan LO White ES Darley V Reed 2000 Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome J Antimicrob Chemother 45 835 841 1:CAS:528:DC%2BD3cXkt1arsL8%3D 10.1093/jac/45.6.835 10837438
16. M Sato K Chida T Suda H Muramatsu Y Suzuki H Hashimoto H Gemma H Nakamura 2006 Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level J Infect Chemother 12 185 189 1:CAS:528:DC%2BD28XptVGgtLk%3D 10.1007/s10156-006- 0446-y 16944256 (Pubitemid 44327186)
17. PA Moise-Broder A Forrest MC Birmingham JJ Schentag 2004 Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections Clin Pharmacokinet 43 925 942 1:CAS:528:DC%2BD2cXhtVGjsr7L 10.2165/00003088-200443130-00005 15509186 (Pubitemid 39447034)
18. M Yasuhara T Iga H Zenda K Okumura T Oguma Y Yano R Hori 1998 Population pharmacokinetics of vancomycin in Japanese pediatric patients Ther Drug Monit 20 612 618 1:CAS:528:DyaK1cXotVGltbk%3D 10.1097/00007691-199812000-00005 9853975 (Pubitemid 28544288)
19. M Yasuhara T Iga H Zenda K Okumura T Oguma Y Yano R Hori 1998 Population pharmacokinetics of vancomycin in Japanese adult patients Ther Drug Monit 20 139 148 1:CAS:528:DyaK1cXisFOqs7o%3D 10.1097/00007691-199804000-00003 9558127 (Pubitemid 28163195)
20. TP Lodise PS McKinnon L Swiderski MJ Rybak 2003 Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia Clin Infect Dis 36 1418 1423 10.1086/375057 12766837 (Pubitemid 36702876)
21. GE Schramm JA Johnson JA Doherty ST Micek MH Kollef 2006 Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment Crit Care Med 34 2069 2074 10.1097/01.CCM.0000227655.41566.3E 16763516 (Pubitemid 44305607)
22. BJ Kopp DE Nix EP Armstrong 2004 Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections Ann Pharmacother 38 1377 1382 10.1345/aph.1E028 15266044 (Pubitemid 39100187)
23. M Wysocki F Delatour F Faurisson A Rauss Y Pean B Misset F Thomas JF Timsit T Similowski H Mentec L Mier D Dreyfuss 2001 Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study Antimicrob Agents Chemother 45 2460 2467 1:CAS:528:DC%2BD3MXmt1emsb4%3D 10.1128/AAC.45.9.2460-2467.2001 11502515 (Pubitemid 32801896)
24. JT Wang CT Fang YC Chen SC Chang 2001 Necessity of a loading dose when using vancomycin in critically ill patients J Antimicrob Chemother 47 246 1:CAS:528:DC%2BD3MXhtlGns74%3D 10.1093/jac/47.2.246 11157921
25. LK Hidayat DI Hsu R Quist KA Shriner A Wong-Beringer 2006 High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity Arch Intern Med 166 2138 2144 10.1001/archinte.166.19.2138 17060545 (Pubitemid 44631403)
26. JM Mylotte JR Aeschlimann DL Rotella 1996 Staphylococcus aureus bacteremia: factors predicting hospital mortality Infect Control Hosp Epidemiol 17 165 168 1:STN:280:DyaK283kvFyktA%3D%3D 10.1086/647264 8708354
27. JM Mylotte A Tayara 2000 Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort Clin Infect Dis 31 1170 1174 1:STN:280:DC%2BD3M%2FotVSmtw%3D%3D 10.1086/317421 11073748 (Pubitemid 32295446)